Late Breaking Abstract - Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma

被引:0
作者
Van Hulst, Glenn [1 ]
Jorssen, Joseph [1 ]
Jacobs, Nathalie [1 ]
Henket, Monique [2 ]
Louis, Renaud [2 ]
Schleich, Florence [3 ]
Bureau, Fabrice [1 ]
Desmet, Christophe [1 ]
机构
[1] Univ Liege, Lab Cellular & Mol Immunol, Liege, Belgium
[2] CHU Liege, Pneumol, Liege, Belgium
[3] Univ Liege, Dept Pulm Med, Liege, Belgium
关键词
Asthma;
D O I
10.1183/13993003.congress-2021.PA890
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
PA890
引用
收藏
页数:2
相关论文
共 23 条
  • [21] Relationship between baseline fraction of exhaled nitric oxide (FeNO) and response to anti-IL-5/5R therapies in severe eosinophilic asthma (SEA)
    Kavanagh, Joanne
    Hearn, Andrew
    Roxas, Cris
    Green, Linda
    Fernandes, Marianna
    Thomson, Louise
    Payne, Victoria
    D'Ancona, Grainne
    Kent, Brian
    Dhariwal, Jaideep
    Nanzer-Kelly, Alexandra
    Jackson, David
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [22] Late Breaking Abstract- Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE)
    Ali, Nasloon
    Lyu, Juntao
    Newell, Anthony
    Sadatsafavi, Mohsen
    Tran, Trung N.
    Price, David B.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [23] Late Breaking Abstract - Early improvement in asthma small airway dysfunction after one dose of SAR443765, a novel bispecific antithymic stromal lymphopoietin/anti-IL-13 nanobody molecule
    Deiteren, Annemie
    Krupka, Emmanuel
    Imberdis, Karine
    Patel, Naimish
    Staudinger, Heribert
    Bas, Selcuk
    Suratt, Benjamin
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62